May 11, 2022 / 07:00PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
To the afternoon session of the Bank of America Healthcare Conference. My name is Geoff Meacham, I'm the senior biopharma analyst here. And we're thrilled today on stage have Bristol-Myers and speaking up of Bristol is Adam Lenkowsky, who is Senior Vice President, General Manager, U.S. Commercial. Adam, welcome.
Adam Lenkowsky - Bristol-Myers Squibb Company - Head of U.S. Oncology
Thank you, Geoff, and thank you so much for having me here. It's a pleasure to be here. As Geoff said, I lead our U.S. commercial organization at BMS. I have responsibility for our oncology, immunology and cardiovascular portfolio. I've been with Bristol now for 25 years and had the great pleasure of those 25 years to have responsibility about half of the time for our oncology portfolio.
So launching Yervoy in the U.S., launching Opdivo, and Opdivo and Yervoy worldwide. And I got to say in my 25 years, this is probably the most exciting time in the time I've been here, with the recent approval
Bristol-Myers Squibb Co at Bank of America Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers